How Abridge became one of the most talked about healthcare AI startups

Ask any of the health-focused VCs to call one of many high AI startups and one identify comes up time and again: an organization  primarily based in Pittsburgh referred to as Abridge. And it’s a startup that launched earlier than OpenAI was a family identify and LLMs entered the frequent Valley vocabulary. 

In 2019, Shiv Rao, a training heart specialist, pitched Andy Weissman, common companion at Union Sq. Ventures, on a startup concept.  Rao referred to as it SoundCloud plus RapGenius for medication.

Whereas Weissman thought that evaluating a nascent AI-powered medical be aware taking app with music internet hosting  and lyrics transcription was just a little humorous, the idea resonated with him.

Rao defined that medical doctors spend as much as two hours a day—sometimes outdoors of standard working hours—typing notes that summarize what was mentioned with their sufferers that day. Such  administrative duties have been inflicting doctor burnout for years, main some to depart the career altogether. Rao satisfied Weissman that the newest improvements in AI might dramatically scale back the period of time medical doctors spend on the ever-growing paperwork burden.

This was years earlier than generative AI took the world by storm and captured VCs’ creativeness.

“It was a reasonably wacky concept. Nobody had carried out it earlier than,” Weissman stated.

However Weissman and different USV companions favored that Rao was not solely a doctor on the College of Pittsburgh Medical Heart but additionally spent half his time as a company enterprise capitalist for that well being system, investing in well being tech startups.  Rao’s workers and advisers have been additionally graduates and professors at Carnegie Mellon, one of many high establishments within the nation for engineering and AI analysis.  

“[Shiv] had this uncommon mixture of abilities: an entrepreneur with a really formidable imaginative and prescient, with a extremely attention-grabbing staff,” Weissman stated. “It felt distinctive.”

Abridge additionally had a fundamental transcription product, which medical doctors might obtain at no cost on their smartphones and begin utilizing throughout their interactions with sufferers. Their utilization fashioned the idea of Abridge’s LLM.

Somewhat over 5 years after USV led a $5 million seed spherical into Rao’s startup Abridge, the corporate has develop into probably the most talked about and quickly rising AI-powered healthcare companies.

Though most companies are nonetheless very cautious about adopting AI tools, massive medical techniques are wanting to signal contracts with Abridge.

“The gross sales cycle for [health systems] may be 18 to 24 months,” stated Rao. “After we began the corporate, we knew what we have been in for.”  However with a four-year lead on a digital scribe product skilled on hundreds of doctor-patient conversations, and now that AI is booming, hospitals are all of a sudden shopping for Abridge at a fast tempo, a stark distinction to their sometimes protracted buying conduct. The corporate has introduced a brand new well being system buyer practically each week for the reason that begin of 2024. 

“We had constructed up all this potential vitality that turned kinetic virtually in a single day in January,” Rao stated. “College of Chicago, Sutter, Yale, Lee Well being, Christus, Emory and the listing goes on and on,” he stated.

Giant hospitals aren’t solely shopping for multi-thousand seat licenses of Abridge however, in lots of instances, publishing glowing opinions about how the well being tech’s software program is altering physicians’ lives. Hospital executives and medical doctors are describing Abridge as “life-changing,” “magical,” and “one of the most important paradigm shifts within our careers.”

One of many largest criticisms of generative AI is that it nonetheless has few substantive enterprise functions. However digital medical be aware taking appears to be a useful software of the novel know-how.

Drowning in paperwork

“I’ve obtained skilled PTSD and battle tales about seeing sufferers after which having to spend hours and hours at evening writing notes and doing all this clerical work that actually distracts from the factor that issues most, which is your affected person, but additionally takes away from your personal private life,” Rao stated.

With Abridge recording within the background, a doctor can focus completely on the affected person with out having to fret about filling out particular fields within the medical document in the course of the go to. 

The payback of AI-powered medical scribes are very straightforward to measure, says Dr. Lee Schwamm, chief digital well being officer at Yale New Haven Medical System, an Abridge buyer. That’s why so many well being techniques are flocking to make use of them, significantly Abridge. . “It is without doubt one of the hottest merchandise within the AI house in the mean time,” he instructed TechCrunch.

As with many administrative issues in well being tech, on the subject of choosing a vendor, a very powerful consideration is value and integration with Epic, an EHR utilized by most massive well being techniques within the US, Schwamm stated. Abridge, which helps 14 international languages, together with Haitian Creole, Brazilian Portuguese and Punjabi, is usually the winner when well being techniques are doing head-to-head comparisons with different AI-powered medical scribes, Schwamm stated.

Earlier this yr, Abridge gained a proper to be integrated inside Epic. After Abridge data a session and a physician stops the recording, “there’s a be aware in English sitting inside Epic ready for them to rapidly confirm, edit and regulate it as they see match,” Rao stated. 

Whereas Abridge seems to be forward of its rivals, which, apart from Microsoft-owned Nuance, embody Ambiance, Nabla and Suki, Schwamm isn’t sure will probably be in a position to preserve its lead over the long run.

“The large query is, do you want a devoted medical LLM to achieve success on this house?” he requested. “Or will the enormous basis fashions, GPT-4o, Google and Meta, get so good that they might ingest a whole corpus of medical notes and begin to ship efficiency that’s comparable?”

That line of inquiry reveals that these are nonetheless early days not only for digital medical be aware taking however for many generative AI firms. The tempo of innovation is quick and livid, and right this moment’s winners might simply lose their edge.

“Abridge is forward by a size, nevertheless it’s early within the race,” Schwamm stated, “A horse can get a foul knee and stumble, or it may possibly maintain getting additional and additional forward.”

For now, most traders TechCrunch talked to agree that Abridge is main the AI-powered medical scribe competitors. Because of this, cash has been pouring into the corporate.

In February, Abridge raised a $150 million Sequence C led by Lightspeed Ventures at a valuation of $850 million.